Guidelines for the management of hydrocephalus associated with aSAH

Subarachnoid Hemorrhage Microchapters
Home
Patient Information
Overview
Classification
Pathophysiology
Causes
Differentiating Subarachnoid Hemorrhage from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
History and Symptoms
Physical Examination
Laboratory Findings
CT
MRI
Other Imaging Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Surgery
Primary Prevention
Secondary Prevention
AHA/ASA Guidelines for the Management of Aneurysmal Subarachnoid Hemorrhage (2012) Risk Factors/Prevention Natural History/Outcome Clinical Manifestations/Diagnosis Medical Measures to Prevent Rebleeding Surgical and Endovascular Methods Hospital Characteristics/Systems of Care Anesthetic Management Cerebral Vasospasm and DCI Hydrocephalus Seizures Associated With aSAH Medical Complications
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
Guidelines for the management of hydrocephalus associated with aSAH On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Guidelines for the management of hydrocephalus associated with aSAH All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Guidelines for the management of hydrocephalus associated with aSAH
CDC on Guidelines for the management of hydrocephalus associated with aSAH
Guidelines for the management of hydrocephalus associated with aSAH in the news
Blogs on Guidelines for the management of hydrocephalus associated with aSAH
Directions to Hospitals Treating Subarachnoid hemorrhage
Risk calculators and risk factors for Guidelines for the management of hydrocephalus associated with aSAH

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-In-Chief: Sara Mehrsefat, M.D. [2]

2012 AHA/ASA Guidelines for the Management of Aneurysmal Subarachnoid Hemorrhage

Management of Hydrocephalus Associated With aSAH: Recommendations

Class I

"1. aSAH-associated acute symptomatic hydrocephalus should be managed by cerebrospinal fluid diversion (EVD or lumbar drainage, depending on the clinical scenario) (Level of Evidence: B)"

"2. aSAH-associated chronic symptomatic hydrocepha- lus should be treated with permanent cerebrospinal fluid diversion (Level of Evidence: C)"

Class III (Harm)

"1. Weaning EVD over >24 hours does not appear to be effective in reducing the need for ventricular shunting (Level of Evidence: B)"

"2. Routine fenestration of the lamina terminalis is not useful for reducing the rate of shunt-dependent hydrocephalus and therefore should not be routinely performed. (Level of Evidence: B)"